BIOCONJUGATION INSIGHTS

Launch Edition

April 2025
Launch Edition
Download PDF

Foreword

Welcome to Bioconjugation Insights

Welcome to Bioconjugation Insights

Lauren Coyle
29 April
Read

Viewpoint

Addressing the shortfalls of LNP-based delivery with conjugate modalities

Addressing the shortfalls of LNP-based delivery with conjugate modalities

Moein Moghimi
28 April
Read
Striking a balance between ADC safety and efficacy

Striking a balance between ADC safety and efficacy

Rakesh Dixit
24 April
Read

Interview

Translating research into therapeutics: the future of ADCs in cancer therapy

Translating research into therapeutics: the future of ADCs in cancer therapy

Yu-Tzu Tai
25 April
Read
Harnessing peptide conjugates strategies for cancer immunotherapy and infectious disease

Harnessing peptide conjugates strategies for cancer immunotherapy and infectious disease

Helen Bright
25 April
Read
Next-generation conjugates: small peptides to transform targeted cancer therapy

Next-generation conjugates: small peptides to transform targeted cancer therapy

Michelle Morrow
25 April
Read

Industry Insights

Industry insights, April 2025

Industry insights, April 2025

Lauren Coyle
28 April
Read
}